✦ LIBER ✦

Cellular immunity towards Thomsen-Friedenreich antigen in breast-carcinoma patients

✍ Scribed by G. F. Springer; M. S. Murthy; P. R. Desai; E. F. Scanlon

Publisher: Springer
Year: 1976
Tongue: English
Weight: 139 KB
Volume: 63
Category: Article
ISSN: 0028-1042
DOI: 10.1007/bf00624027

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Breast cancer patient's cell-mediated im

Breast cancer patient's cell-mediated immune response to thomsen-friedenreich (T) antigen

✍ Georg F. Springer; M. Satya Murthy; Parimal R. Desai; Edward F. Scanlon 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 654 KB

Thomsen-Friedenreich (T) antigenic specificity as determined with human serum anti-T was found in reactive form in breast adenocarcinomata but not in healthy and generally not in benign breast tissues. T-antigenic specificity was demonstrable in all metastatic breast carcinoma lesions. T specificity

Thomsen-Friedenreich antigen presents as

Thomsen-Friedenreich antigen presents as a prognostic factor in colorectal carcinoma : A clinicopathologic study of 264 patients

✍ Stephan E. Baldus; Thomas K. Zirbes; Franz-Georg Hanisch; Doreen Kunze; Sven T. 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 431 KB 👁 2 views

## BACKGROUND. Up to now, the expression of the tumor-associated Thomsen-Friedenreich (TF) antigen in colorectal carcinoma has not been thoroughly investigated with particular emphasis on its correlation with established clinicopathologic characteristics and classifications as well as its prognosti

Differences in T-cell immunity toward tu

Differences in T-cell immunity toward tumor-associated antigens in colorectal cancer and breast cancer patients

✍ Dirk Nagorsen; Carmen Scheibenbogen; Gerhard Schaller; Binta Leigh; Alexander Sc 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 95 KB

## Abstract There is increasing evidence that tumors elicit specific T‐cell responses in a substantial proportion of patients. Recently, we have shown that in patients with colorectal cancer specific T cells against the tumor‐associated antigens (TAA) Ep‐CAM, her‐2/neu or CEA can be detected in per